Report #2883301

Overview

Sex

Unknown

Age

Age unknown

State

PA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

a patient of their clinic was previously administered GARDASIL 9 series back in 2018 and was recently administered another series of GARDASIL 9; No additional AE; This Spontaneous report was received from Nurse prescriber and referred to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. On an unknown date in 2018, patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (Dose Text: 0.5 mL / Two or Three dose series)(strength, route, anatomical location, lot#, and expiration date were not provided) as prophylaxis. On an unknown date, the patient reticently received another Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (Dose Text: 0.5 mL / Two or Three dose series)(strength, route, anatomical location, lot#, and expiration date were not provided) as prophylaxis, completed on an unspecified date in September 2025. Reporter stated that the patient was unaware that they were previously administered a GARDASIL 9 series (Extra dose administered). No additional AE (No adverse event). Lot # is being requested and will be submitted if received.